Talon Wins U.S. FDA Approval for Blood Cancer Treatment

Talon Therapeutics Inc.’s blood-cancer treatment, Marqibo, won approval from U.S. regulators, giving the company its first marketed product.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.